World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
94
Citations
43478
World Ranking
555
National Ranking
259

John E. Bennett publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where John E. Bennett sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 242 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

John E. Bennett D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where John E. Bennett sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 94 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

John E. Bennett is affiliated with the National Institutes of Health in the United States. Their research spans primarily the field of Medicine, with a focus on Epidemiology, Infectious Diseases, Immunology, Pulmonary and Respiratory Medicine, and Genetics. The bulk of their work addresses topics related to fungal infections and antifungal resistance, with additional interest in nail diseases, immunodeficiency and autoimmune disorders, genomics of rare diseases, genetic factors in colorectal cancer, and ear and head tumors.

Bennett's recent scholarly output includes several publications from 2020 to 2022 in respected journals. Notable papers include:

  • "Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations," 2022, Journal of Allergy and Clinical Immunology
  • "Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory Syndrome," 2020, Clinical Infectious Diseases
  • "Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci," 2021, Nature Communications
  • "Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection," 2021, mBio
  • "Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis," 2022, Journal of Clinical Investigation

Frequent coauthors collaborating with Bennett include:

  • Peter R. Williamson
  • Christa S. Zerbe
  • Seher Anjum
  • Kyung J. Kwon-Chung
  • Steven M. Holland

Bennett's work has been published across several key venues in infectious diseases and immunology, such as:

  • The Journal of Infectious Diseases
  • Journal of Allergy and Clinical Immunology
  • Clinical Infectious Diseases
  • Nature Communications
  • mBio

Their research topics reflect sustained investigation into fungal infections and antifungal resistance. The focus on genetic and immunologic factors further emphasizes contributions in understanding host-pathogen interactions, particularly in immunodeficiency and autoimmune contexts.

Best Publications

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

    S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett

  • Aspergillosis. The spectrum of the disease in 98 patients.

    Robert C. Young;John E. Bennett;Charles L. Vogel;Paul P. Carbone

  • A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

    John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas

  • Practice Guidelines for Diseases Caused by Aspergillus

    David A. Stevens;David A. Stevens;David A. Stevens;Virginia L. Kan;Virginia L. Kan;Marc A. Judson;Marc A. Judson;Vicki A. Morrison

  • An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

    Andrew H. Limper;Kenneth S. Knox;George A. Sarosi;Neil M. Ampel

  • Prognostic Factors in Cryptococcal Meningitis: A Study in 111 Cases

    Richard D. Diamond;John E. Bennett

  • Cryptococcosis in the acquired immunodeficiency syndrome.

    Joseph A. Kovacs;Andrea A. Kovacs;Michael Polis;W. Craig Wright

  • Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

    Reginald E. Greene;Haran T. Schlamm;Jörg W. Oestmann;Paul Stark

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

    K J Kwon-Chung;I Polacheck;J E Bennett

  • Epidemiologic differences between the two varieties of Cryptococcus neoformans

    K. J. Kwon-Chung;J. E. Bennett

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans.

    S D Salas;J E Bennett;K J Kwon-Chung;J R Perfect

  • Chronic Mucocutaneous Candidiasis: Model-Building in Cellular Immunity

    Charles H. Kirkpatrick;Robert R. Rich;John E. Bennett

  • Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

    Arthur S. Levine;Stuart E. Siegel;Alan D. Schreiber;Janet Hauser

  • Nephrotoxicity of amphotericin B. Early and late effects in 81 patients.

    William T. Butler;John E. Bennett;David W. Alling;Paul T. Wertlake

  • Executive summary: Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.

    Kyung J. Kwon-Chung;John E. Bennett;Brian L. Wickes;Wieland Meyer

Frequent Co-Authors

Peter R. Williamson
Peter R. Williamson National Institutes of Health
John H. Rex
John H. Rex The University of Texas Health Science Center at Houston
Thomas F. Patterson
Thomas F. Patterson The University of Texas Health Science Center at San Antonio
Raoul Herbrecht
Raoul Herbrecht University of Strasbourg
David A. Stevens
David A. Stevens Stanford University
Kyung J. Kwon-Chung
Kyung J. Kwon-Chung National Institutes of Health
Kieren A. Marr
Kieren A. Marr Johns Hopkins University School of Medicine
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Peter Aaby
Peter Aaby University of Southern Denmark
David W. Denning
David W. Denning University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in microbiology opens doors to numerous healthcare and science-related careers. For those interested in combining microbiology knowledge with health information management, exploring a cahiim accredited him degree online can provide valuable skills in managing patient data and healthcare systems.

If you seek quicker entry into the healthcare field, consider an accelerated course such as a medical billing and coding certificate online accelerated. This path offers foundational knowledge applicable in many medical settings where microbiology concepts support accurate diagnostic coding.

For those looking for high-paying roles linked to microbiology and healthcare, exploring various online healthcare degrees that pay well can be advantageous. These programs often integrate microbiology with clinical practice, opening diverse employment opportunities.

Additionally, public health professionals with a microbiology background might find pursuing one of the easy mph online programs to get into a strategic step. These programs provide essential knowledge for managing and preventing infectious diseases on a community scale.

Best Scientists Citing John E. Bennett

Trending Scientists

Recently Published Articles